Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Mukherjee S. et al, (2024), Eur J Cancer, 209

Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy.

Hughes D. et al, (2024), Sci Adv, 10

Include forthcoming?